Mediators of Inflammation

Mediators of Inflammation / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 787042 |

Jueun Oh, Ji Hye Kim, Jae Gwang Park, Young-Su Yi, Kye Won Park, Ho Sik Rho, Min-Seuk Lee, Jae Won Yoo, Seung-Hyun Kang, Yong Deog Hong, Song Seok Shin, Jae Youl Cho, "Radical Scavenging Activity-Based and AP-1-Targeted Anti-Inflammatory Effects of Lutein in Macrophage-Like and Skin Keratinocytic Cells", Mediators of Inflammation, vol. 2013, Article ID 787042, 8 pages, 2013.

Radical Scavenging Activity-Based and AP-1-Targeted Anti-Inflammatory Effects of Lutein in Macrophage-Like and Skin Keratinocytic Cells

Academic Editor: Giamila Fantuzzi
Received11 Dec 2012
Accepted10 Jan 2013
Published07 Mar 2013


Lutein is a naturally occurring carotenoid with antioxidative, antitumorigenic, antiangiogenic, photoprotective, hepatoprotective, and neuroprotective properties. Although the anti-inflammatory effects of lutein have previously been described, the mechanism of its anti-inflammatory action has not been fully elucidated. Therefore, in the present study, we aimed to investigate the regulatory activity of lutein in the inflammatory responses of skin-derived keratinocytes or macrophages and to elucidate the mechanism of its inhibitory action. Lutein significantly reduced several skin inflammatory responses, including increased expression of interleukin-(IL-) 6 from LPS-treated macrophages, upregulation of cyclooxygenase-(COX-) 2 from interferon-γ/tumor necrosis-factor-(TNF-) α-treated HaCaT cells, and the enhancement of matrix-metallopeptidase-(MMP-) 9 level in UV-irradiated keratinocytes. By evaluating the intracellular signaling pathway and the nuclear transcription factor levels, we determined that lutein inhibited the activation of redox-sensitive AP-1 pathway by suppressing the activation of p38 and c-Jun-N-terminal kinase (JNK). Evaluation of the radical and ROS scavenging activities further revealed that lutein was able to act as a strong anti-oxidant. Taken together, our findings strongly suggest that lutein-mediated AP-1 suppression and anti-inflammatory activity are the result of its strong antioxidative and p38/JNK inhibitory activities. These findings can be applied for the preparation of anti-inflammatory and cosmetic remedies for inflammatory diseases of the skin.

1. Introduction

Inflammatory responses of the skin are largely due to infections with various bacteria and fungi, chemical irritation such as from sodium lauryl sulfate 2,4-dinitrophenol (DNP), and exposure of ultraviolet (UV) light, which lead to skin rash [14]. When such immunogens or irritants stimulate epithelial cells, macrophages, keratinocytes, mast cells, and Langerhans cells of the skin layer, various inflammatory mediators, including interferon-(IFN-) γ, tumor-necrosis-factor-(TNF-) α, interleukin-(IL-) 6, cyclooxygenase-(COX-) 2, and matrix metalloproteinases (MMP), are produced and evoke the symptoms of inflammation [57]. Activation of inflammatory cells and consequent expression of numerous inflammatory genes [811] result from toll-like-receptor-(TLR-) dependent [12, 13] or-independent stimulation of intracellular signaling cascades, which are composed of nonreceptor protein tyrosine kinases and serine-threonine protein kinases such as mitogen-activated protein kinases (e.g., p38, extracellular signal-regulated kinase [ERK], c-Jun N-terminal kinase [JNK]), as well as the activation and upregulation of nuclear factor (NF)-κB and activator protein (AP)-1 transcription factors [14, 15].

Lutein (Figure 1) is one of naturally occurring carotenoids with antioxidative, antitumorigenic, antiangiogenic, photoprotective, hepatoprotective, and neuroprotective properties [1619]. Previous reports have suggested that this compound is able to ameliorate in vitro and in vivo inflammatory responses by suppressing NF-κB activation [20, 21]. These findings strongly suggest a role of lutein in modulating inflammatory processes by regulating cellular redox potential. However, despite numerous studies, the mechanism underlying the anti-inflammatory activity of lutein remains unclear.

Because understanding skin inflammation is of interest to numerous cosmetic and pharmaceutical companies that develop skin-targeted biomaterials, exploring the effect of lutein on skin inflammation and its anti-inflammatory mechanism was undertaken. In the present study, the effect of lutein treatment on the expression of proinflammatory mediators in macrophages and keratinocytes treated with LPS, IFN-γ/TNF-α, and UV, and the action mechanism of lutein were carefully investigated.

2. Materials and Methods

2.1. Materials

Lutein (95% purity), β-carotene (Figure 1), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), sodium nitroprusside (SNP), 2′7′-dichlorodihydrofluorescein diacetate (DCF-DA), and lipopolysaccharide (LPS; E. coli 0111:B4) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). U0126 (U0), SB203580 (SB), and SP600125 (SP) were obtained from Calbiochem (La Jolla, CA, USA). Fetal bovine serum and RPMI 1640 were obtained from Gibco (Grand Island, NY, USA). The murine macrophage cell line RAW264.7 (ATCC No.: TIB-71) and the human keratinocyte cell line HaCaT (ATCC No.: HB-8065) were purchased from the ATCC (Rockville, MD, USA). All other chemicals were of analytical grade and were obtained from Sigma. Phosphospecific or total antibodies to AP-1 family proteins (c-Fos, c-Jun, and FRA-1), IκBα, ERK, p38, JNK, MKK3/6, MKK4/7, TAK1, lamin A/C, and β-actin were obtained from Cell Signaling (Beverly, MA, USA).

2.2. Cell Culture

RAW264.7 and HaCaT cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco, Grand Island, NY, USA), glutamine, and antibiotics (penicillin and streptomycin) at 37°C under 5% CO2. For each experiment, cells were detached with a cell scraper. When the cells were cultured for the experiments at 2 × 106 cells/mL, the proportion of dead cells was less than 1% as determined by trypan blue dye exclusion.

2.3. Cell Viability Test

RAW264.7 and HaCaT cells (  cells/mL) were cultured for 18 h, after which lutein (0 to 50 μM) was added to the cells for the final 24 h of culture. The cytotoxic effect of lutein was then evaluated by a conventional MTT assay, as reported previously [22, 23]. For the final 3 h of culture, 10 μL MTT solution (10 mg/mL in phosphate-buffered saline, pH 7.4) was added to each well. The incubation was halted by the addition of 15% sodium dodecyl sulfate (SDS) into each well, which solubilized the formazan [24]. Absorbance at 570 nm ( ) was measured using a SpectraMax 250 microplate reader (BioTex, Bad Friedrichshall, Germany).

2.4. Measurement of mRNA or Protein Levels of IL-6, COX-2, and MMP-9

RAW264.7 and HaCaT cells (  cells/mL) were cultured for 18 h, then pretreated with lutein (0 to 40 μM) for 30 min, and further cultured with LPS (1 μg/mL) or IFN-γ (20 ng/mL)/TNF-α (20 ng/mL) for 6 h or UV-irradiated for 27.5 s. The inhibitory effect of lutein on the expression of IL-6 and COX-2 was determined by semiquantitative and real-time quantitative RT-PCR [25, 26]. The protein levels of MMP-9 were detected by immunoblotting analysis.

2.5. mRNA Analysis by Semiquantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

To determine cytokine mRNA expression levels, total RNA was isolated from LPS-treated RAW264.7 cells using TRIzol Reagent (Gibco BRL), according to the manufacturer’s instructions. Total RNA was stored at −70°C until use. Semiquantitative (sq) or real-time quantitative (q) RT-PCR reactions were conducted as reported previously [27, 28]. The primers (Bioneer, Daejeon, Korea) used in these reactions are listed in Table 1.

GenePrimer sequences

IL-6 (sqPCR)
IL-6 (qPCR)
COX-2 (sqPCR)

2.6. Preparation of the Cell Lysates and Nuclear Fractions, Immunoblotting, and Immunoprecipitation

RAW264.7 or HaCaT cells (  cells/mL) were washed three times in cold PBS with 1 mM sodium orthovanadate, resuspended in lysis buffer (20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 2 mM ethylene glycol tetraacetic acid, 50 mM β-glycerophosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 1% Triton X-100, 10% glycerol, 10 μg/mL aprotinin, 10 μg/mL pepstatin, 1 mM benzamide, and 2 mM PMSF), and lysed by sonication with rotation for 30 min at 4°C. The lysates were clarified by centrifugation at 16,000 ×g for 10 min at 4°C and stored at −20°C until use.

Nuclear lysates were prepared following a three-step procedure [29]. After treatment, cells were collected with a rubber policeman, washed with PBS, and lysed on ice for 4 min in 500 μL lysis buffer containing 50 mM KCl, 0.5% Nonidet P-40, 25 mM HEPES (pH 7.8), 1 mM phenylmethylsulfonyl fluoride, 10 μg/mL leupeptin, 20 μg/mL aprotinin, and 100 μM 1,4-dithiothreitol (DTT). Cell lysates were then centrifuged at 19,326 ×g for 1 min. For the second step, the nuclear fraction pellet was washed once in the washing buffer (identical to the lysis buffer described above, except without Nonidet P-40). In the final step, the nuclei were treated with an extraction buffer containing 500 mM KCl, 10% glycerol, and the other reagents listed for the lysis buffer above. The nuclei/extraction buffer mixture was frozen at −80°C, then thawed on ice, and centrifuged at 19,326 ×g for 5 min. The supernatant was collected as the nuclear extract. Soluble cell lysates were immunoblotted, and protein levels were visualized as previously reported [30]. For immunoprecipitation, cell lysates containing equal amounts of protein (500 μg) from RAW264.7 cells (  cells/mL) treated with or without LPS (1 μg/mL) for 2.5 min were precleared with 10 μL protein A-coupled sepharose beads (50% v/v) (Amersham, Little Chalfont, Buckinghamshire, UK) for 1 h at 4°C. Pre-cleared samples were incubated with 5 μL anti-p38 or JNK antibodies overnight at 4°C. Immune complexes were then mixed with 10 μL protein A-coupled sepharose beads (50% v/v) and rotated for 3 h at 4°C.

2.7. p38 Enzyme Activity Assay

To determine the effect of lutein on LPS-activated p38 activity, immunoprecipitated p38 (prepared from RAW264.7 cells (  cells/mL) that had been treated with LPS for 30 min in the presence or absence of lutein) was incubated with ATF-2 according to the manufacturer’s instructions. The p38 kinase activity was determined using an anti-phospho-ATF-2 antibody after immunoblotting analysis, as reported previously [31].

2.8. Neutralizing Activity of SNP-Derived Radicals and UV-Induced ROS

Lutein radicals scavenging activity was determined by measuring neutralizing activity of nitric oxide (NO.) released with SNP (20 mM) by spontaneous decomposition. The absorbance of the chromophore was measured at 540 nm. Percent inhibition of NO generation was measured by comparing the absorbance values of negative controls (10 mM sodium nitroprusside and vehicle) to assay preparations. For detection of reactive oxygen species (ROS) production, HaCaT cells were incubated with 50 μM DCF-DA in culture medium for 30 min in a CO2 incubator. The cells were then rinsed with PBS to eliminate non-incorporated DCF-DA and treated with lutein, (β)-carotene, or vitamin C during UV-B exposure. The cells were imaged with a confocal laser-scanning microscope (Carl Zeiss, LSM510).

2.9. Statistical Analysis

Data (Figures 2(a), 2(d), and 4(a)) were expressed as the mean ± standard deviation (SD) as calculated from one ( ) of two independent experiments. Other data were representative of three different experiments with similar results. For statistical comparisons, results were analyzed using analysis of variance/Scheffe’s post hoc test and the Kruskal-Wallis/Mann-Whitney test. All values < 0.05 were considered statistically significant. All statistical tests were conducted using SPSS (SPSS Inc., Chicago, IL, USA).

3. Results and Discussion

Lutein is one of spontaneously generating carotenoids with anti-oxidative, anti-tumorigenic, anti-angiogenic, photoprotective, hepatoprotective, and neuroprotective properties [1619]. Although the anti-inflammatory property of lutein has been suggested, the mechanism of lutein-mediated anti-inflammatory action in various skin inflammatory responses remains largely unclear. Therefore, in the present study, we aimed to elucidate the anti-inflammatory activity of lutein and its inhibitory mechanism by mimicking skin inflammatory conditions.

First, the ability of lutein to attenuate inflammatory responses in macrophages and skin-derived keratinocytic (HaCaT) cells during various pro-inflammatory conditions induced by LPS, IFN-γ/TNF-α, and UV-irradiation [7, 32] was examined. Interestingly, this compound significantly suppressed the expression of IL-6 mRNA, a major cytokine involved in skin inflammation [33], as determined by quantitative (Figure 2(a), left panel) or semiquantitative (Figure 2(a), right panel) RT-PCR. Under the conditions, however, up to 30 μM of lutein exhibited no cytotoxic activity in RAW264.7 cells (Figure 2(d) left panel). In addition, lutein suppressed the expression of COX-2 induced by cotreatment with IFN-γ and TNF-α (Figure 2(b)), indicating that this compound is able to block the production of inflammatory mediators in the skin. Moreover, this compound also suppressed MMP-9 expression triggered by UV irradiation (Figure 2(c)) without altering the viability of HaCaT cells (Figure 2(d) right panel), indicating that lutein is also able to protect against UV irradiation-mediated skin irritation. It has been previously reported that lutein can decrease the edematous cutaneous response as illustrated by the reduction of the UVB-induced increase of ear bifold thickening [34], that aromatic carotenoids can prevent UV-induced DNA damage in human skin fibroblasts [35], and that lutein can suppress melanogenesis [36]. In agreement with these studies, our data further confirm that lutein can be used as a skin protective agent with anti-inflammatory functions.

Furthermore, to evaluate the inhibitory activity of lutein on the expression of pro-inflammatory genes, we examined the inflammatory signaling pathways and corresponding transcription factors activated in response to pro-inflammatory stimuli (e.g., LPS). Interestingly, we determined that the inhibition of IL-6 mRNA expression by lutein was a result of the suppression of nuclear translocation of p-FRA and c-Fos (Figure 3(a)), major components of AP-1 family [37]. Although NF-κB has been previously reported to be a major target transcription factor [21, 38], we did not observe a strong inhibitory pattern of p65/p50 translocation in response to LPS (data not shown), and the degradation level of IκBα was not restored by lutein treatment (Figure 3(b)). Because the activation of AP-1 is known to be mediated by the phosphorylation of MAPK (p38, ERK, and JNK) [39], we next examined whether lutein is capable of reducing the levels of the phosphoproteins. Intriguingly, this compound was found to clearly suppress the phosphorylation of p38 and JNK at 15 to 30 μM (Figure 3(b)). Furthermore, the phosphorylation of MKK3/6 and MKK4/7 but not TAK1 at 30 min and MKK4/7 at 60 min was strongly diminished by 30 μM of lutein (Figure 3(c)). The formation of signaling complex composed of JNK and c-Fos or p38 and c-Jun (Figure 3(d)) and kinase activity of p38 upregulated by LPS (Figure 3(e)) were also remarkably reduced by this compound, implying that suppression of p38 and JNK phosphorylation pathways might negatively affect the molecular interaction between MAPK (p38 and JNK) and AP-1 family proteins. In agreement with this finding, the inhibitors (SP600125 (SP) and SB203580 (SB)) of JNK and p38, as well as lutein (10 and 30 μM), strongly reduced the expression of IL-6 (Figure 3(f)), suggesting a role of JNK- and p38-mediated signaling cascade in IL-6 expression. Although lutein has not been reported to modulate AP-1 activation signaling, structural derivatives, such as lycopene, β-carotene, or β-cryptoxanthin, were considered as AP-1 regulatory compounds [4042]. Thus, these data strongly indicate a role of lutein in negative regulation of AP-1-mediated inflammatory gene expression.

How this compound can interrupt p38/AP-1 pathway activated by LPS is not clear yet in this study. However, because AP-1 pathway is an important inflammatory signaling pathway activated by intracellular ROS [43], we next evaluated the antioxidative activity of lutein in blocking AP-1 activation by suppressing ROS generation as an approach of mechanistic understandings. As predicted, this compound strongly neutralized SNP-induced radical generation (Figure 4(a)). Similarly, noncytotoxic concentrations of lutein (Figure 2(d)) also dramatically scavenged the elevated ROS generated by UV irradiation (Figure 4(b)), indicating that UV irradiation-mediated cellular responses can be reverted by lutein treatment. Indeed, this compound strongly suppressed the expression of MMP-9 (Figure 2(c)), a marker of acute inflammation [44], implying that lutein is capable of modulating UV-mediated inflammatory and cellular damage by suppressing radical generation. In addition, lutein has been reported to reduce oxidative stress induced by benzo(a)pyrene [45], hypercholesterolemic diet [46], H2O2 [47], and D-galactose [48]. Taken together, these prior reports and our new data suggest that the radical scavenging activity of lutein is a common feature observed in lutein pharmacology.

In summary, our findings demonstrate that lutein strongly inhibits several skin inflammatory responses such as expression of IL-6, COX-2, and MMP-9 from LPS-treated macrophages, IFN-γ/TNF-α-stimulated HaCaT cells, and UV-irradiated keratinocytes. By examining the intracellular signaling cascade and the nuclear levels of transcription factor, we demonstrate that lutein can suppress the activation of redox-sensitive AP-1 pathway. Based on the radical and ROS scavenging activity of lutein, it was concluded that the AP-1-targeted anti-inflammatory activity of lutein was due to its anti-oxidative activity. Therefore, our results strongly suggest that due to its anti-oxidative properties, lutein can be used as an anti-inflammatory and cosmetic remedy for inflammatory diseases of the skin.

Authors’ Contribution

Jueun Oh and Ji Hye Kim equally contributed to this work.

Conflict of Interests

The authors report no conflict of interests. The authors alone are responsible for the content and writing of the paper.


This work was supported by the National Institute of Biological Resources (NIBR) grant funded by the Korean government (ME).


  1. I. Kurokawa, F. W. Danby, Q. Ju et al., “New developments in our understanding of acne pathogenesis and treatment,” Experimental Dermatology, vol. 18, no. 10, pp. 821–832, 2009. View at: Publisher Site | Google Scholar
  2. J. Kim, “Review of the innate immune response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses,” Dermatology, vol. 211, no. 3, pp. 193–198, 2005. View at: Publisher Site | Google Scholar
  3. Y. Suzuki and C. Ra, “Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy,” Journal of Pharmacological Sciences, vol. 110, no. 3, pp. 237–244, 2009. View at: Publisher Site | Google Scholar
  4. M. Yoshizumi, T. Nakamura, M. Kato et al., “Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes, HaCaT,” Cell Biology International, vol. 32, no. 11, pp. 1405–1411, 2008. View at: Publisher Site | Google Scholar
  5. I. T. Harvima and G. Nilsson, “Mast cells as regulators of skin inflammation and immunity,” Acta Dermato-Venereologica, vol. 91, no. 6, pp. 644–650, 2011. View at: Google Scholar
  6. R. J. Toncic, J. Lipozencic, I. Martinac, and S. Gregurić, “Immunology of allergic contact dermatitis,” Acta Dermatovenerologica Croatica, vol. 19, no. 1, pp. 51–68, 2011. View at: Google Scholar
  7. C. Vestergaard, N. Kirstejn, B. Gesser, J. T. Mortensen, K. Matsushima, and C. G. Larsen, “IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis,” Journal of Dermatological Science, vol. 26, no. 1, pp. 46–54, 2001. View at: Publisher Site | Google Scholar
  8. B. Bresnihan, “Pathogenesis of joint damage in rheumatoid arthritis,” The Journal of Rheumatology, vol. 26, no. 3, pp. 717–719, 1999. View at: Google Scholar
  9. G. R. Burmester, B. Stuhlmüller, G. Keyszer, and R. W. Kinne, “Mononuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis?” Arthritis and Rheumatism, vol. 40, no. 1, pp. 5–18, 1997. View at: Publisher Site | Google Scholar
  10. J. A. Gracie, R. J. Forsey, W. L. Chan et al., “A proinflammatory role for IL-18 in rheumatoid arthritis,” Journal of Clinical Investigation, vol. 104, no. 10, pp. 1393–1401, 1999. View at: Google Scholar
  11. T. J. Kang, J. S. Moon, S. Lee, and D. Yim, “Polyacetylene compound from Cirsium japonicum var. ussuriense inhibits the LPS-induced inflammatory reaction via suppression of NF-κB activity in RAW 264.7 cells,” Biomolecules and Therapeutics, vol. 19, no. 1, pp. 97–101, 2011. View at: Publisher Site | Google Scholar
  12. R. W. Kinne, R. Bräuer, B. Stuhlmüller, E. Palombo-Kinne, and G. R. Burmester, “Macrophages in rheumatoid arthritis,” Arthritis Research, vol. 2, no. 3, pp. 189–202, 2000. View at: Publisher Site | Google Scholar
  13. T. Owens, A. A. Babcock, J. M. Millward, and H. Toft-Hansen, “Cytokine and chemokine inter-regulation in the inflamed or injured CNS,” Brain Research Reviews, vol. 48, no. 2, pp. 178–184, 2005. View at: Publisher Site | Google Scholar
  14. Y. Sekine, T. Yumioka, T. Yamamoto et al., “Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages,” Journal of Immunology, vol. 176, no. 1, pp. 380–389, 2006. View at: Google Scholar
  15. K. Takeda and S. Akira, “Roles of Toll-like receptors in innate immune responses,” Genes to Cells, vol. 6, no. 9, pp. 733–742, 2001. View at: Publisher Site | Google Scholar
  16. X. R. Xu, Z. Y. Zou, X. Xiao, Y. M. Huang, X. Wang, and X. M. Lin, “Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population,” Journal of Atherosclerosis and Thrombosis, 2012. View at: Publisher Site | Google Scholar
  17. K. Izumi-Nagai, N. Nagai, K. Ohgami et al., “Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2555–2562, 2007. View at: Publisher Site | Google Scholar
  18. M. Sasaki, Y. Ozawa, T. Kurihara et al., “Neuroprotective effect of an antioxidant, lutein, during retinal inflammation,” Investigative Ophthalmology and Visual Science, vol. 50, no. 3, pp. 1433–1439, 2009. View at: Publisher Site | Google Scholar
  19. M. Pinto-Marijuan, R. Joffre, I. Casals et al., “Antioxidant and photoprotective responses to elevated CO(2) and heat stress during holm oak regeneration by resprouting, evaluated with NIRS (near-infrared reflectance spectroscopy),” Plant Biology, vol. 15, supplement 1, pp. 5–17, 2013. View at: Publisher Site | Google Scholar
  20. J. E. Kim, J. O. Leite, R. deOgburn, J. A. Smyth, R. M. Clark, and M. L. Fernandez, “A Lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs,” The Journal of Nutrition, vol. 141, no. 8, pp. 1458–1463, 2011. View at: Publisher Site | Google Scholar
  21. J. H. Kim, H. J. Na, C. K. Kim et al., “The non-provitamin A carotenoid, lutein, inhibits NF-κB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-κB-inducing kinase pathways: role of H2O2 in NF-κB activation,” Free Radical Biology and Medicine, vol. 45, no. 6, pp. 885–896, 2008. View at: Publisher Site | Google Scholar
  22. R. Pauwels, J. Balzarini, M. Baba et al., “Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds,” Journal of Virological Methods, vol. 20, no. 4, pp. 309–321, 1988. View at: Google Scholar
  23. H. Yang, S. E. Lee, S. I. Jeong, C. S. Park, Y. H. Jin, and Y. S. Park, “Up-regulation of heme oxygenase-1 by Korean red ginseng water extract as a cytoprotective effect in human endothelial cells,” Journal of Ginseng Research, vol. 35, no. 3, pp. 352–359, 2011. View at: Publisher Site | Google Scholar
  24. J. R. Kim, D. R. Oh, M. H. Cha et al., “Protective effect of polygoni cuspidati radix and emodin on Vibrio vulnificus cytotoxicity and infection,” Journal of Microbiology, vol. 46, no. 6, pp. 737–743, 2008. View at: Publisher Site | Google Scholar
  25. T. Shen, J. Lee, M. H. Park et al., “Ginsenoside Rp1, a ginsenoside derivative, blocks promoter activation of iNOS and Cox-2 genes by suppression of an IKKβ-mediated NF-κB pathway in HEK293 cells,” Journal of Ginseng Research, vol. 35, no. 2, pp. 200–208, 2011. View at: Publisher Site | Google Scholar
  26. H. J. Kim, S. G. Lee, I. G. Chae et al., “Antioxidant effects of fermented red ginseng extracts in streptozotocin- induced diabetic rats,” Journal of Ginseng Research, vol. 35, no. 2, pp. 129–137, 2011. View at: Publisher Site | Google Scholar
  27. T. Yu, Y. J. Lee, H. M. Yang et al., “Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE2 production is mediated by suppression of NF-κB and AP-1 activation signaling cascade,” Journal of Ethnopharmacology, vol. 134, no. 1, pp. 11–17, 2011. View at: Publisher Site | Google Scholar
  28. J. Kwon, S. Kim, S. Shim, D. S. Choi, J. H. Kim, and Y. B. Kwon, “Modulation of LPS-stimulated astroglial activation by ginseng total saponins,” Journal of Ginseng Research, vol. 35, no. 1, pp. 80–85, 2011. View at: Publisher Site | Google Scholar
  29. S. E. Byeon, Y. G. Lee, B. H. Kim et al., “Surfactin blocks NO production in lipopolysaccharide-activated macrophages by inhibiting NF-κB activation,” Journal of Microbiology and Biotechnology, vol. 18, no. 12, pp. 1984–1989, 2008. View at: Publisher Site | Google Scholar
  30. J. Y. Lee, Y. G. Lee, J. Lee et al., “Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects,” Journal of Biological Chemistry, vol. 285, no. 13, pp. 9932–9948, 2010. View at: Publisher Site | Google Scholar
  31. T. Shen, J. Lee, E. Lee, S. H. Kim, T. W. Kim, and J. Y. Cho, “Cafestol, a coffee-specific diterpene, is a novel extracellular signal-regulated kinase inhibitor with AP-1-targeted inhibition of prostaglandin E2 production in lipopolysaccharide-activated macrophages,” Biological and Pharmaceutical Bulletin, vol. 33, no. 1, pp. 128–132, 2010. View at: Publisher Site | Google Scholar
  32. D. W. C. Hunt, W. A. Boivin, L. A. Fairley et al., “Ultraviolet B light stimulates interleukin-20 expression by human epithelial keratinocytes,” Photochemistry and Photobiology, vol. 82, no. 5, pp. 1292–1300, 2006. View at: Publisher Site | Google Scholar
  33. K. W. Nam, J. K. Noh, S. K. Kim et al., “Essential oil of Thujopsis dolobrata suppresses atopic dermatitis- like skin lesions in NC/Nga mice,” Biomolecules and Therapeutics, vol. 19, no. 1, pp. 102–108, 2011. View at: Publisher Site | Google Scholar
  34. S. González, S. Astner, W. An, D. Goukassian, and M. A. Pathak, “Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice,” Journal of Investigative Dermatology, vol. 121, no. 2, pp. 399–405, 2003. View at: Publisher Site | Google Scholar
  35. S. Wagener, T. Volker, S. de Spirt, H. Ernst, and W. Stahl, “3,3'-dihydroxyisorenieratene and isorenieratene prevent UV-induced DNA damage in human skin fibroblasts,” Free Radical Biology & Medicine, vol. 53, no. 3, pp. 457–463, 2012. View at: Publisher Site | Google Scholar
  36. H. Kai, M. Baba, and T. Okuyama, “Inhibitory effect of Cucumis sativus on melanin production in melanoma B16 cells by downregulation of tyrosinase expression,” Planta Medica, vol. 74, no. 15, pp. 1785–1788, 2008. View at: Publisher Site | Google Scholar
  37. M. R. Griffiths, E. J. Black, A. A. Culbert et al., “Insulin-stimulated expression of c-fos, fra1 and c-jun accompanies the activation of the activator protein-1 (AP-1) transcriptional complex,” Biochemical Journal, vol. 335, no. 1, pp. 19–26, 1998. View at: Google Scholar
  38. R. Krishnaswamy, S. N. Devaraj, and V. V. Padma, “Lutein protects HT-29 cells against Deoxynivalenol-induced oxidative stress and apoptosis: prevention of NF-κB nuclear localization and down regulation of NF-κB and cyclooxygenase-2 expression,” Free Radical Biology and Medicine, vol. 49, no. 1, pp. 50–60, 2010. View at: Publisher Site | Google Scholar
  39. M. Karin and E. Gallagher, “TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes,” Immunological Reviews, vol. 228, no. 1, pp. 225–240, 2009. View at: Publisher Site | Google Scholar
  40. S. H. Jang, J. W. Lim, and H. Kim, “Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells,” Journal of Physiology and Pharmacology, vol. 60, supplement 7, pp. 131–137, 2009. View at: Google Scholar
  41. P. Palozza, A. Catalano, R. Simone, and A. Cittadini, “Lycopene as a guardian of redox signalling,” Acta Biochimica Polonica, vol. 59, no. 1, pp. 21–25, 2012. View at: Google Scholar
  42. C. Liu, R. T. Bronson, R. M. Russell, and X. D. Wang, “β-cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets,” Cancer Prevention Research, vol. 4, no. 8, pp. 1255–1266, 2011. View at: Publisher Site | Google Scholar
  43. Y. Lavrovsky, B. Chatterjee, R. A. Clark, and A. K. Roy, “Role of redox-regulated transcription factors in inflammation, aging and age-related diseases,” Experimental Gerontology, vol. 35, no. 5, pp. 521–532, 2000. View at: Publisher Site | Google Scholar
  44. Y. S. Hamirani, S. Pandey, J. J. Rivera et al., “Markers of inflammation and coronary artery calcification: a systematic review,” Atherosclerosis, vol. 201, no. 1, pp. 1–7, 2008. View at: Publisher Site | Google Scholar
  45. V. Vijayapadma, P. Ramyaa, D. Pavithra, and R. Krishnaswamy, “Protective effect of lutein against benzo(a)pyrene-induced oxidative stress in human erythrocytes,” Toxicology and Industrial Health. In press. View at: Google Scholar
  46. J. E. Kim, R. M. Clark, Y. Park, J. Lee, and M. L. Fernandez, “Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet,” Nutrition Research and Practice, vol. 6, no. 2, pp. 113–119, 2012. View at: Publisher Site | Google Scholar
  47. S. Gao, T. Qin, Z. Liu et al., “Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells,” Molecular Vision, vol. 17, pp. 3180–3190, 2011. View at: Google Scholar
  48. J. Mai, X. Shen, D. Shi, Y. Wei, H. Shen, and M. Wu, “Effect of lutein on relieving oxidative stress in mice induced by D-galatose,” Wei Sheng Yan Jiu, vol. 39, no. 4, pp. 430–432, 2010. View at: Google Scholar

Copyright © 2013 Jueun Oh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.